Estrella Immunopharma | SC 13D:超過5%持股股東披露文件-Eureka Therapeutics, Inc.(71.8%)
Estrella Immunopharma | 3:首次持股聲明-首席財務官 Xu Jiandong
Estrella Immunopharma | 3:首次持股聲明-董事 Roberts Marsha
Estrella Immunopharma | 3:首次持股聲明-董事 Xu Pei
Estrella Immunopharma | 3:首次持股聲明-首席執行官 Liu Cheng
Estrella Immunopharma | 3:首次持股聲明-董事 Wu Xuejun Janelle
Estrella Immunopharma | 3:首次持股聲明-董事 Wu Fan
Estrella Immunopharma | 3:首次持股聲明-股東 Eureka Therapeutics, Inc.
Estrella Immunopharma | 4:持股變動聲明-股東 Owl Creek Asset Management, L.P.
Estrella Immunopharma | 4:持股變動聲明-其他相關方 TradeUP Acquisition Sponsor LLC
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Long James
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Jiang Tao
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Wen Luqi
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Li Jianwei
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Twigg Weston
Estrella Immunopharma | 4:持股變動聲明-其他相關方 Yang Weiguang
Tradeup Acquisition Corp | SC 13G/A:超過5%持股股東披露文件(修正)-Karpus Investment Management(0%)
Tradeup Acquisition Corp | SC 13G/A:超過5%持股股東披露文件(修正)-ATW SPAC MANAGEMENT LLC(0.0%),Antonio Ruiz-Gimenez(0.0%)
Tradeup Acquisition Corp | SC 13G/A:超過5%持股股東披露文件(修正)-Karpus Investment Management(14.75%)
Tradeup Acquisition Corp | SC 13G/A:超過5%持股股東披露文件(修正)-Boothbay Fund Management, LLC(0%),Boothbay Absolute Return Strategies LP(0%)等
暫無數據